BLUE vs. ABBV

Last updated Jun 5, 2026

BLUE (bluebird bio, Inc.) and ABBV (AbbVie Inc.) are both stocks. Both are in the Healthcare sector — BLUE in Biotechnology, ABBV in Drug Manufacturers - General. At a 0.23 correlation, their price movements are largely independent.

Performance

BLUE vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in bluebird bio, Inc. (BLUE) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BLUE

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ABBV

• 1D: 3.60%
• 1M: 9.14%
• YTD: 0.06%
• 6M: -0.03%
• 1Y: 23.98%
• 3Y*: 22.32%
• 5Y*: 19.28%
• 10Y*: 18.38%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BLUE vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BLUE bluebird bio, Inc.	0.00%	-40.41%	-69.78%	-80.06%	-30.73%	-64.35%	-50.69%	-11.54%	-44.30%	188.65%
ABBV AbbVie Inc.	0.06%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Correlation

The correlation between BLUE and ABBV is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (10Y) Calculated over the trailing 10-year period	0.20
Correlation (All Time) Calculated using the full available price history since Jun 20, 2013	0.23

The correlation between BLUE and ABBV shifts across timeframes, from 0.03 (3 years) to 0.23 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM) BLUE : $103.95M ABBV : $62.82B
Gross Profit (TTM) BLUE : $28.19M ABBV : $46.15B
EBITDA (TTM) BLUE : -$115.82M ABBV : $17.96B

Return for Risk

BLUE vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABBV

ABBV Risk / Return Rank: 68
ABBV Sharpe Ratio Rank: 72
ABBV Sortino Ratio Rank: 66
ABBV Omega Ratio Rank: 65
ABBV Calmar Ratio Rank: 68
ABBV Martin Ratio Rank: 68

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLUE vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for bluebird bio, Inc. (BLUE) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	BLUE	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.99	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.85	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.72	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.74	—

Drawdowns

Drawdown Indicators

	BLUE	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	—	-45.09%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-17.32%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-20.74%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-21.92%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-45.09%	—
Current Drawdown Current decline from peak	—	-5.77%	—
Average Drawdown Average peak-to-trough decline	—	-10.73%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	7.70%	—

Volatility

Volatility by Period

	BLUE	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.21%	—
Volatility (6M) Calculated over the trailing 6-month period	—	17.96%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	24.22%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	22.90%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	25.76%	—

Dividends

BLUE vs. ABBV - Dividend Comparison

BLUE has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.00%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABBV AbbVie Inc.	3.00%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
BLUE bluebird bio, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both BLUE and ABBV in my portfolio?

BLUE and ABBV have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.